The Lahore High Court’s (LHC) single bench comprising Justice Ayesha A Malik on Tuesday summoned health officials in the case of controversial purchase of hepatitis medicine.
A local pharmaceutical company challenged the decision of the health authorities in LHC through Barrister Raheel Kamran Sheikh.
As per to details, health authorities have imposed conditions while purchasing hepatitis medicine which were favourable for only one multinational company among all in Pakistan depriving local companies of the level playing field.
These conditions had nothing to do with the law, rules and regulation but were aimed to benefit a blue-eyed company of some officials while no advertisement was published before the tender was awarded to keep deal secret, the petitioner said. The local companies view the conditions as against the constitution, law, Drug Act and based on malafide intentions.
They pleaded to declare the proceedings in relation to the procurement of medicine for the year 2014-2015 unconstitutional, void ab initio, illegal, malafide and of no legal effect.
The court after hearing the arguments directed health services director general and other respondents including the multinational pharmaceutical company to appear before the court to explain their position.
